- Investing Ideas
- /
- German Undervalued Stocks Based On Cash Flows
German Undervalued Stocks Based On Cash Flows
Results
27
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
27 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HNL | €17.40 | 5.5% | -22.7% | €105.5m | €25.20 | PS1x | E121.4% | n/a | Capital Goods | ||
CY1K | €2.90 | -1.4% | -57.0% | €28.1m | €7.00 | PB0.8x | E102.7% | n/a | Capital Goods | ||
SBS | €41.90 | -5.8% | -17.4% | €509.3m | €42.33 | PE41.9x | E21.9% | 1.3% | Healthcare | ||
STM | €43.85 | -2.2% | -17.5% | €1.1b | €63.44 | PE14.7x | E20.5% | 4.0% | Capital Goods | ||
RTV | €2.52 | -1.6% | 0% | €38.6m | €2.80 | PS13.7x | E116.8% | n/a | Media | ||
CHG | €24.20 | -1.6% | 66.9% | €473.1m | €27.00 | PS6.7x | E73.4% | n/a | Healthcare | ||
TTR1 | €17.10 | -4.2% | -35.2% | €118.1m | €21.50 | PE18.5x | E29.4% | 3.6% | Capital Goods | ||
MTX | €247.80 | -1.0% | 8.2% | €13.3b | €248.90 | PS2.4x | E34.9% | 0.8% | Capital Goods | ||
RSL2 | €18.40 | -0.5% | -17.1% | €118.5m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
SANT | €19.61 | -2.2% | 2.1% | €1.2b | €30.42 | PE16.1x | E21.1% | 2.5% | Software | ||
E4C | €12.90 | -1.1% | -31.6% | €45.3m | €40.50 | PE29.9x | E46.7% | 3.6% | Telecom | ||
SAP | €181.50 | -3.3% | 51.5% | €210.3b | €199.16 | PE81.7x | E34.0% | 1.2% | Software | ||
ADS | €227.10 | -1.9% | 29.9% | €40.5b | €233.18 | PE477x | E41.0% | 0.3% | Consumer Durables | ||
AEIN | €16.95 | -1.2% | -28.3% | €194.0m | €32.63 | PE14.5x | E25.2% | 2.9% | Software | ||
ST5 | €32.55 | 5.7% | -2.8% | €458.4m | €39.50 | PE27.2x | E20.6% | 0% | Capital Goods | ||
V3S | €10.60 | -2.3% | 90.0% | €85.4m | €10.25 | PS2.3x | E118.7% | 0% | Tech | ||
R3NK | €24.86 | -4.4% | n/a | €2.5b | €31.88 | PE78.9x | E32.8% | 1.2% | Capital Goods | ||
BSL | €10.52 | -4.4% | -34.3% | €323.4m | €15.70 | PS1.7x | E84.0% | 0% | Tech | ||
ISHA | €2.02 | 0% | 6.3% | €29.5m | €2.60 | PB2.6x | E80.5% | n/a | Software | ||
GXI | €95.70 | -5.0% | -10.2% | €3.3b | €134.06 | PE28.6x | E22.3% | 1.3% | Pharmaceuticals & Biotech | ||
LPK | €7.88 | -6.6% | -4.0% | €192.9m | €12.05 | PE58.2x | E51.7% | n/a | Tech | ||
M12 | €16.15 | -6.1% | 100.4% | €295.8m | €27.50 | PE28.8x | E24.4% | 3.1% | Healthcare | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SJJ | €11.80 | 8.3% | 38.5% | €123.9m | €19.75 | PS1.3x | E111.5% | 0% | Software |